An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data

• Gerd Rüdiger BurmesterCharité – Universitätsmedizin Berlin
• Jeffrey R. CurtisUniversity of Alabama at Birmingham
• Huifeng YunUniversity of Alabama at Birmingham
• Oliver FitzGeraldSt. Vincent's University Hospital
• Kevin L. WinthropOregon Health & Science University
• Valderílio Feijó AzevedoUniversidade Federal do Paraná
• William F. C. RigbyDartmouth College
• Keith S. KanikPfizer (United States)
• Cunshan WangPfizer (United States)
• Pinaki BiswasPfizer (United States)
• Thomas V. JonesPfizer (United States)
• Niki PalmettoPfizer (United States)
• Thijs K. HendrikxPfizer (United States)
• Sujatha S. MenonPfizer (United States)
• Ricardo RojoPfizer (United States)